Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000711377-10-000005)

Filing Details

Accession Number:: 0000711377-10-000005
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2010-04-19 13:00:00
Reporting Period:: 2010-04-16

Filing Date:: 2010-04-19
Accepted Time:: 2010-04-19 06:40:37
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
711377	Neogen Corp	NEOG	In Vitro & In Vivo Diagnostic Substances (2835)	382367843

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1189021	Edward Bradley		Vice President	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2010-04-16	5,575	$9.02	115,095	No	4	M	Direct
Common Stock	Disposition	2010-04-16	5,575	$25.80	109,520	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Common Stock Option (Right-to-buy)	Disposition	2010-04-16	5,575	$0.00	5,575	$9.02

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
81,780		2011-11-03	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	14,012	Indirect	(1) See Footnote

Footnotes

Held in Company 401-K Plan
The options were granted 11/3/06 and became exercisable 20% yearly thereafter